Pangaea Oncology, S.A. (BME:PANG)
Spain · Delayed Price · Currency is EUR 1.580
+0.030 (1.94%)
May 29, 2026, 4:00 PM CET
Pangaea Oncology Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -3.6 | -1.17 | -4.66 | -2.71 | -0.64 |
Depreciation & Amortization | 1.29 | 1.34 | 0.75 | 0.39 | 0.37 |
Other Amortization | 1.49 | 1.24 | 1.07 | 0.85 | 0.62 |
Asset Writedown & Restructuring Costs | - | -0.02 | 0.51 | 0.15 | 0.13 |
Loss (Gain) on Equity Investments | - | - | 0.06 | 0.16 | 0.19 |
Provision & Write-off of Bad Debts | - | - | 0.49 | 0.13 | - |
Other Operating Activities | -2.64 | -3.8 | -1.44 | -2.56 | -1.7 |
Change in Accounts Receivable | -1.07 | -1.44 | 0.39 | -0.27 | -0.75 |
Change in Inventory | -0.01 | -0.23 | -0.13 | 0.08 | -0.04 |
Change in Accounts Payable | 0.45 | -0.1 | 0.7 | 0.11 | -0.43 |
Change in Other Net Operating Assets | 1.57 | -0.31 | -0.13 | 0 | -0.25 |
Operating Cash Flow | -2.52 | -4.57 | -2.4 | -3.68 | -2.5 |
Capital Expenditures | -0.45 | -0.48 | -0.26 | -0.02 | -0.03 |
Cash Acquisitions | - | -0.07 | -1.53 | - | - |
Sale (Purchase) of Intangibles | -0.02 | -0.04 | -0.04 | - | -0 |
Investment in Securities | 0.03 | 0.31 | 0.25 | -0.73 | -0.77 |
Investing Cash Flow | -0.44 | -0.27 | -1.58 | -0.75 | -0.8 |
Short-Term Debt Issued | - | - | 0.09 | - | 0.25 |
Long-Term Debt Issued | 4.81 | 2.46 | 1.73 | - | 0.2 |
Total Debt Issued | 4.81 | 2.46 | 1.82 | - | 0.45 |
Short-Term Debt Repaid | - | - | - | -0.16 | -0.79 |
Long-Term Debt Repaid | -4.59 | -1.86 | -1.47 | -1.57 | -0.98 |
Total Debt Repaid | -4.59 | -1.86 | -1.47 | -1.72 | -1.77 |
Net Debt Issued (Repaid) | 0.21 | 0.59 | 0.36 | -1.72 | -1.31 |
Issuance of Common Stock | 1.4 | 6.36 | 0.06 | 11.23 | 6.41 |
Repurchase of Common Stock | -0.01 | -0.16 | -2.23 | - | -0.02 |
Other Financing Activities | - | - | 0.07 | - | - |
Financing Cash Flow | 1.6 | 6.79 | -1.74 | 9.5 | 5.08 |
Foreign Exchange Rate Adjustments | - | - | - | - | -0.01 |
Net Cash Flow | -1.36 | 1.95 | -5.72 | 5.08 | 1.77 |
Free Cash Flow | -2.97 | -5.05 | -2.65 | -3.7 | -2.53 |
Free Cash Flow Margin | -17.74% | -30.08% | -26.66% | -55.36% | -37.67% |
Free Cash Flow Per Share | -0.08 | - | -0.09 | -0.12 | -0.11 |
Cash Interest Paid | 0.3 | 0.3 | 0.12 | 0.19 | 0.27 |
Cash Income Tax Paid | -0.15 | -0.09 | 0.11 | -0.08 | -0.75 |
Levered Free Cash Flow | -0.87 | -2.44 | 0.2 | -0.83 | -0.78 |
Unlevered Free Cash Flow | -0.68 | -2.25 | 0.28 | -0.71 | -0.62 |
Change in Working Capital | 0.94 | -2.09 | 0.83 | -0.08 | -1.47 |